Status:

COMPLETED

Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal Gastrectomy

Lead Sponsor:

Korean South West East Gastric Surgery Group

Conditions:

Gastric Cancer

Complication of Surgical Procedure

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Laparoscopic gastrectomy has fewer infectious complications compared to open surgery. Recently, the incidence of postoperative infectious complications was greatly reduced due to the development of su...

Detailed Description

The purpose of this study was to investigate the non-inferiority of incidence of infectious complications in the experimental group that did not use prophylactic antibiotics compared to the control gr...

Eligibility Criteria

Inclusion

  • A patient undergoing totally laparoscopic distal gastrectomy for the gastric cancer located in the low or middle part of the stomach
  • A patient who underwent limited lymphadenectomy (D1 or D1+) with clinical T1-2N0M0 stage based on 8th edition of the International Union Against Cancer (UICC) tumor node metastasis (TNM) classification
  • From 18 to 75 years old
  • Eastern Cooperative Oncology Group (ECOG) status 0-1
  • American Society of Anesthesiologists (ASA) score I-II
  • A patient with appropriate bone marrow function, renal function, lung function, and liver function
  • Before the surgery, decide to participate in this study and agree with the written informed consent

Exclusion

  • A patient who underwent previous abdominal surgery
  • Combined other abdominal organ cancer
  • A patient who received chemotherapy and radiotherapy within the last 6 months
  • Combined organ resection other than cholecystectomy
  • A patient undergoing emergency surgery due to perforation or bleeding
  • A patient who have received antibiotic treatment for other infectious diseases within one month of operation
  • Severely malnourished patient

Key Trial Info

Start Date :

December 27 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 25 2022

Estimated Enrollment :

260 Patients enrolled

Trial Details

Trial ID

NCT03802097

Start Date

December 27 2018

End Date

March 25 2022

Last Update

April 6 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chonnam National University Hwasun Hospital

Hwasun, Jellanamdo, South Korea, 58128